Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of pelvic organ prolapse and urinary incontinence
3.2.1.2 Growing awareness towards timely diagnosis and treatment
3.2.1.3 Increasing adoption of non-invasive treatment options
3.2.1.4 Growing government support in women health programs
3.2.2 Industry pitfalls and challenges
3.2.2.1 Social stigma and psychological barrier
3.2.2.2 Concerns related to risk of infections due to prolonged use
3.3 Growth potential analysis
3.4 Patent analysis
3.5 Gap analysis
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Ring
5.3 Donut
5.4 Gellhorn
5.5 Other types
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Mild pelvic organ prolapse
6.3 Stress urinary incontinence
6.4 Severe pelvic organ prolapse
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Clinics
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Artisan Medical
9.2 Bioteque America
9.3 Bliss GVS Pharma
9.4 Bray Group (Ethos Partners)
9.5 Coloplast Group
9.6 Contiform International
9.7 CooperSurgical
9.8 Dr. Arabin
9.9 Integra Lifesciences
9.10 MedGyn Products
9.11 Novomed group (Gyneas)
9.12 Panpac Medical
9.13 Personal Medical
9.14 Smiths Group
9.15 Sugar International
